10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 311,764 | 327,379 | 334,820 | 222,379 | 234,459 |
| Marketable Securities | 45,643 | 65,506 | 85,970 | 210,238 | 218,435 |
| Receivables | 103,847 | 87,685 | 77,940 | 104,211 | 83,549 |
| Inventories | 80,917 | 83,687 | 82,307 | 81,629 | 78,629 |
| TOTAL | $562,348 | $582,940 | $601,894 | $635,035 | $629,422 |
| Non-Current Assets | |||||
| PPE Net | 285,008 | 284,913 | 292,106 | 289,328 | 257,694 |
| Intangibles | 26,344 | 26,801 | 27,459 | 27,369 | 28,004 |
| Other Non-Current Assets | 74,840 | 94,984 | 92,571 | 77,248 | 81,087 |
| TOTAL | $386,192 | $406,698 | $412,136 | $393,945 | $366,785 |
| Total Assets | $948,540 | $989,638 | $1,014,030 | $1,028,980 | $996,207 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,836 | 23,124 | 29,317 | 21,599 | 21,594 |
| Accrued Expenses | 64,733 | 56,460 | 64,960 | 92,454 | 90,203 |
| TOTAL | $104,717 | $98,087 | $112,006 | $130,957 | $126,855 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,143 | 9,217 | 8,530 | 7,867 | 6,665 |
| Other Non-Current Liabilities | 98,607 | 98,250 | 99,639 | 89,115 | 93,560 |
| TOTAL | $98,607 | $98,250 | $99,639 | $92,280 | $93,560 |
| Total Liabilities | $203,324 | $196,337 | $211,645 | $223,237 | $220,415 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,209 | 117,418 | 116,192 | 115,357 | 114,464 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,235,468 | -1,142,482 | -1,080,068 | -1,029,321 | -1,012,106 |
| Other shareholders' equity | -677 | -969 | -1,479 | -4,335 | -5,492 |
| TOTAL | $745,216 | $793,301 | $802,385 | $805,743 | $775,792 |
| Total Liabilities And Equity | $948,540 | $989,638 | $1,014,030 | $1,028,980 | $996,207 |